$29.99 $31.99 You Save 6% ($2.00)
Checkout the All New Mythical Unicorn Pre, a Magical Energy Pre-Workout with OxyGold. If you're looking for mythical levels of strength, magical levels of energy, and a tasty flavor tested and approved by Unicorns themselves, then you've come to the right place. Grab yourself a tub of Glitter Punch and experience workouts like you've never experienced before!
Serving Size: 1 Scoop (5.1g)
Servings Per Container: 35
Unicorn Pre Blend 3.5g
Beta Alanine, Taurine< Betaine Anhydrous, Caffeine Anhydrous, AMPiberry (Juniperus Communis)(berry), OxyGold (Fulvic Acid), Rauwolfia Vomitoria Extract (std. min. 90% alpha Yohimbine)(rootbark)
*Daily Value Not Established
For adult use only. Use only as directed. Ensure to drink enough fluid before, during, and afer exercise. Consult a health care practitioner prior to use; if you are pregnant or breastfeeding, if you have any known or suspected medical conditions, and/or if you are taking any prescriptions or OTC medications. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, mate) is not recommended. This product is not intended as a substitute for sleep. This product contains milk by-products/derivatives. Do not use if packaging has been tampered with. Store in a cool, dry place and keep out of direct sunlight.
Bais S, Gill NS, Rana N, Shandil S. A Phytopharmacological Review on a Medicinal Plant: Juniperus communis. Int Sch Res Notices. 2014;2014:634723. Published 2014 Nov 11. doi:10.1155/2014/634723
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897106/
Akhondzadeh S, Amiri A, Bagheri AH. Efficacy and Safety of Oral Combination of Yohimbine and L-arginine (SX) for the Treatment of Erectile Dysfunction: a multicenter, randomized, double blind, placebo-controlled clinical trial. Iran J Psychiatry. 2010;5(1):1–3.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430403/
Winkler J, Ghosh S. Therapeutic Potential of Fulvic Acid in Chronic Inflammatory Diseases and Diabetes. J Diabetes Res. 2018;2018:5391014. Published 2018 Sep 10. doi:10.1155/2018/5391014
